FDA's Center for Drug Evaluation and Research warns consumers about taking more of the anti-diarrheal drug loperamide than indicated, the center's second warning about a common OTC ingredient in as many days.
Monitoring reports of adverse events, including 10 deaths, prompts concern about the ingredient used in OTCs including McNeil Consumer Healthcare's Imodium A-D and in private label and store brand...